Neurological and psychological applications of transcranial lasers and LEDs

Biochemical Pharmacology

Volumn 86, Issue 4, 2013, Pages 447-457

  Rojas, Julio C ^a,b   Gonzalez Lima, F ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cognitive enhancement; Cytochrome oxidase; Low level light therapy; Methylene blue; Neuroprotection; Photobiomodulation

Indexed keywords

CYTOCHROME C OXIDASE;

ARTICLE; BRAIN FUNCTION; BRAIN REGION; CELL SURVIVAL; ENERGY ABSORPTION; ENERGY METABOLISM; HUMAN; LOW LEVEL LASER THERAPY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXYGEN CONSUMPTION; PERFUSION; PRIORITY JOURNAL; RESPIRATORY CHAIN; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84884906148     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.06.012     Document Type: Note

References (75)

1. Lampl Y. Laser treatment for stroke. Expert Rev Neurother 2007;7:961-5. (Pubitemid 47281311)
2. Hashmi JT, Huang YY, Osmani BZ, Sharma SK, Naeser MA, Hamblin MR. Role of low-level laser therapy in neurorehabilitation. PM&R 2010;2:S292-305.
3. Rojas JC, Gonzalez-Lima F. Low-level light therapy of the eye and brain. Eye Brain 2011;3:49-67.
4. Rojas JC, Bruchey AK, Gonzalez-Lima F. Low-level light therapy improves cortical metabolic capacity and memory retention. J Alzheimers Dis 2012;32:741-52.
5. Rojas JC, Lee J, John JM, Gonzalez-Lima F. Neuroprotective effects of nearinfrared light in an in vivo model of mitochondrial optic neuropathy. J Neurosci 2008;28:13511-21.
6. Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol 2012;96:32-45.
7. Wong-Riley MT, Liang HL, Eells JT, Chance B, Henry MM, Buchmann E, et al. Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J Biol Chem 2005;280:4761-71. (Pubitemid 40288647)
8. Mochizuki-Oda N, Kataoka Y, Cui Y, Yamada H, Heya M, Awazu K. Effects of near-infra-red laser irradiation on adenosine triphosphate and adenosine diphosphate contents of rat brain tissue. Neurosci Lett 2002;323:207-10. (Pubitemid 34311913)
9. Liang HL, Whelan HT, Eells JT, Meng H, Buchmann E, Lerch-Gaggl A, et al. Photobiomodulation partially rescues visual cortical neurons from cyanideinduced apoptosis. Neuroscience 2006;139:639-49.
10. Ying R, Liang HL, Whelan HT, Eells JT, Wong-Riley MT. Pretreatment with nearinfrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity. Brain Res 2008;1243:167-73.
11. Schiffer F, Johnston AL, Ravichandran C, Polcari A, Teicher MH, Webb RH, et al. Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct 2009;5:46.
12. Wong-Riley MT, Nie F, Hevner RF, Liu S. Brain cytochrome oxidase: functional significance and bigenomic regulation in the CNS. In: Gonzalez-Lima F, editor. Cytochrome oxidase in neuronal metabolism and Alzheimer's disease. New York: Springer; 1998. p. 1-53.
13. Barrett DW, Gonzalez-Lima F. Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans. Neuroscience 2013;230:13-23.
14. Naeser MA, Saltmarche A, Krengel MH, Hamblin MR, Knight JA. Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed Laser Surg 2010;29:351-8.
15. Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, et al. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke 2007;38:1843-9. (Pubitemid 46847257)
16. Zivin JA, Albers GW, Bornstein N, Chippendale T, Dahlof B, Devlin T, et al. Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke 2009;40:1359-64.
17. Karu TI, Pyatibrat LV, Kolyakov SF, Afanasyeva NI. Absorption measurements of a cell monolayer relevant to phototherapy: reduction of cytochrome c oxidase under near IR radiation. J Photochem Photobiol B 2005;81:98-106. (Pubitemid 41574466)
18. Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng 2012;40:516-33.
19. Jenkins PA, Carroll JD. How to report low-level laser therapy (LLLT)/photomedicine dose and beam parameters in clinical and laboratory studies. Photomed Laser Surg 2011;29:785-7.
20. De Taboada L, Yu J, El-Amouri S, Gattoni-Celli S, Richieri S, McCarthy T, et al. Transcranial laser therapy attenuates amyloid-beta peptide neuropathology in amyloid-beta protein precursor transgenic mice. J Alzheimers Dis 2011;23:521-35.
21. Bashkatov AN, Genina EA. Optical properties of human cranial bone in the spectral range from 800 to 2000 nm. Proc SPIE 2006;6163:61630.
22. Lapchak PA, Wei J, Zivin JA. Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbits. Stroke 2004;35:1985-8. (Pubitemid 38971888)
23. De Taboada L, Ilic S, Leichliter-Martha S, Oron U, Oron A, Streeter J. Transcranial application of low-energy laser irradiation improves neurological deficits in rats following acute stroke. Lasers Surg Med 2006;38:70-3. (Pubitemid 43238086)
24. Oron A, Oron U, Chen J, Eilam A, Zhang C, Sadeh M, et al. Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke 2006;37:2620-4. (Pubitemid 44454688)
25. Lapchak PA, Salgado KF, Chao CH, Zivin JA. Transcranial near-infrared light therapy improves motor function following embolic strokes in rabbits: an extended therapeutic window study using continuous and pulse frequency delivery modes. Neuroscience 2007;148:907-14. (Pubitemid 47432824)
26. Oron A, Oron U, Streeter J, de Taboada L, Alexandrovich A, Trembovler V, et al. Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits. J Neurotrauma 2007;24:651-6. (Pubitemid 46996025)
27. Michalikova S, Ennaceur A, van Rensburg R, Chazot PL. Emotional responses and memory performance of middle-aged CD1 mice in a 3D maze: effects of low infrared light. Neurobiol Learn Mem 2008;89:480-8. (Pubitemid 351484243)
28. Lapchak PA, Han MK, Salgado KF, Streeter J, Zivin JA. Safety profile of transcranial near-infrared laser therapy administered in combination with thrombolytic therapy to embolized rabbits. Stroke 2008;39:3073-8.
29. Ahmed NA, Radwan NM, Ibrahim KM, Khedr ME, El Aziz MA, Khadrawy YA. Effect of three different intensities of infrared laser energy on the levels of amino acid neurotransmitters in the cortex and hippocampus of rat brain. Photomed Laser Surg 2008;26:479-88.
30. Moreira MS, Velasco IT, Ferreira LS, Ariga SK, Barbeiro DF, Meneguzzo DT, et al. Effect of phototherapy with low intensity laser on local and systemic immunomodulation following focal brain damage in rat. J Photochem Photobiol B 2009;97:145-51.
31. Lapchak PA, De Taboada L. Transcranial near infrared laser treatment (NILT) increases cortical adenosine-50-triphosphate (ATP) content following embolic strokes in rabbits. Brain Res 2010;1306:100-5.
32. Uozumi Y, Nawashiro H, Sato S, Kawauchi S, Shima K, Kikuchi M. Targeted increase in cerebral blood flow by transcranial near-infrared laser irradiation. Lasers Surg Med 2010;42:566-76.
33. Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, et al. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment. J Comp Neurol 2010;518:25-40.
34. Yip KK, Lo SC, Leung MC, So KF, Tang CY, Poon DM. The effect of low-energy laser irradiation on apoptotic factors following experimentally induced transient cerebral ischemia. Neuroscience 2011;190:301-6.
35. Ando T, Xuan W, Xu T, Dai T, Sharma SK, Kharkwal GB, et al. Comparison of therapeutic effects between pulsed and continuous wave 810 nm wavelength laser irradiation for traumatic brain injury in mice. PLoS One 2011;6:e26212.
36. Quirk BJ, Torbey M, Buchmann E, Verma S, Whelan HT. Near-infrared photobiomodulation in an animal model of traumatic brain injury: improvements at the behavioral and biochemical levels. Photomed Laser Surg 2012;30:523-9.
37. Wu Q, Xuan W, Ando T, Xu T, Huang L, Huang YY, et al. Low-level laser therapy for closed-head traumatic brain injury in mice: effect of different wavelengths. Lasers Surg Med 2012;44:218-26.
38. Oron A, Oron U, Streeter J, De Taboada L, Alexandrovich A, Trembovler V, et al. Near infrared transcranial laser therapy applied at various modes to mice following traumatic brain injury significantly reduces long-term neurological deficits. J Neurotrauma 2012;29:401-7.
39. Khuman J, Zhang J, Park J, Carroll JD, Donahue C, Whalen MJ. Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice. J Neurotrauma 2012;29:408-17.
40. Xuan W, Vatansever F, Huang L, Wu Q, Xuan Y, Dai T, et al. Transcranial lowlevel laser therapy improves neurological performance in traumatic brain injury in mice: effect of treatment repetition regimen. PLoS One 2013;8:e53454.
41. Moro C, Torres N, El Massri N, Ratel D, Johnstone DM, Stone J, et al. Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains. BMC Neurosci 2013;14:40.
42. Byrnes KR, Wu X, Waynant RW, Ilev IK, Anders JJ. Low power laser irradiation alters gene expression of olfactory ensheathing cells in vitro. Lasers Surg Med 2005;37:161-71. (Pubitemid 41266301)
43. Leal Junior EC, Lopes-Martins RA, Frigo L, De Marchi T, Rossi RP, de Godoi V, et al. Effects of low-level laser therapy (LLLT) in the development of exerciseinduced skeletal muscle fatigue and changes in biochemical markers related to postexercise recovery. J Orthop Sports Phys Ther 2010;40:524-32.
44. Drummond SP, Bischoff-Grethe A, Dinges DF, Ayalon L, Mednick SC, Meloy MJ. The neural basis of the psychomotor vigilance task. Sleep 2005;28:1059-68. (Pubitemid 41279502)
45. Nieder A, Miller EK. A parieto-frontal network for visual numerical information in the monkey. PNAS 2004;101:7457-62. (Pubitemid 38638054)
46. Jang H, Lee H. Meta-analysis of pain relief effects by laser irradiation on joint areas. Photomed Laser Surg 2012;30:405-17.
47. Pastore D, Greco M, Passarella S. Specific helium-neon laser sensitivity of the purified cytochrome c oxidase. Int J Radiat Biol 2000;76:863-70. (Pubitemid 30352770)
48. Schirmer RH, Adler H, Pickhardt M, Mandelkow E. Lest we forget you- methylene blue. . .. Neurobiol Aging 2011;32. 2325.e7-16.
49. Karu TI, Pyatibrat LV, Kalendo GS. Cell attachment modulation by radiation from a pulsed light diode (lambda = 820 nm) and various chemicals. Lasers Surg Med 2001;28:227-36. (Pubitemid 32275290)
50. Karu TI, Pyatibrat LV, Kalendo GS, Esenaliev RO. Effects of monochromatic lowintensity light and laser irradiation on adhesion of HeLa cells in vitro. Lasers Surg Med 1996;18:171-7. (Pubitemid 26063008)
51. Ohlow MJ, Moosmann B. Phenothiazine: the seven lives of pharmacology's first lead structure. Drug Discovery Today 2011;16:119-31.
52. Zhang X, Rojas JC, Gonzalez-Lima F. Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neurotoxicity Res 2006;9:47-57.
53. Gabrielli D, Belisle E, Severino D, Kowaltowski AJ, Baptista MS. Binding, aggregation and photochemical properties of methylene blue in mitochondrial suspensions. Photochem Photobiol 2004;79:227-32.
54. Lee RB, Urban JP. Functional replacement of oxygen by other oxidants in articular cartilage. Arthritis Rheum 2002;46:3190-200. (Pubitemid 35453528)
55. Furian AF, Fighera MR, Oliveira MS, Ferreira AP, Fiorenza NG, de Carvalho Myskiw J, et al. Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum. Neurochem Int 2007;50:164-71. (Pubitemid 44879673)
56. Rojas JC, John JM, Lee J, Gonzalez-Lima F. Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy. Neurotoxicity Res 2009;15:260-73.
57. Medina DX, Caccamo A, Oddo S. Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol 2011;21:140-9.
58. O'Leary 3rd JC, Li Q, Marinec P, Blair LJ, Congdon EE, Johnson AG, et al. Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Mol Neurodegener 2010;5:45.
59. Callaway NL, Riha PD, Wrubel KM, McCollum D, Gonzalez-Lima F. Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neurosci Lett 2002;332:83-6. (Pubitemid 35217846)
60. Riha PD, Rojas JC, Gonzalez-Lima F. Beneficial network effects of methylene blue in an amnestic model. Neuroimage 2011;54:2623-34.
61. Deiana S, Harrington CR, Wischik CM, Riedel G. Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology 2009;202:53-65.
62. Calabrese EJ. Hormesis: principles and applications for pharmacology and toxicology. Am J Pharmacol Toxicol 2008;3:59-71.
63. Bruchey AK, Behavioral Gonzalez-Lima F, Physiological. Biochemical hormetic responses to the autoxidizable dye methylene blue. Am J Pharmacol Toxicol 2008;3:72-9.
64. Huang YY, Sharma SK, Carroll J, Hamblin MR. Biphasic dose response in low level light therapy-an update. Dose-Response (a publication of International Hormesis Society) 2011;9:602-18.
65. National Institute of Neurological Disorders and Stroke. Stroke: hope through research. National Institutes of Health; 2004.
66. National Institute of Aging. Alzheimer's disease progress report: intensifying the research effort. U.S. Department of Health & Human Services, NIH; 2012.
67. Arntzen KA, Schirmer H, Johnsen SH, Wilsgaard T, Mathiesen EB. Carotid atherosclerosis predicts lower cognitive test results: a 7-year follow-up study of 4371 stroke-free subjects-the Tromso study. Cerebrovasc Dis 2012;33:159-65.
68. Valla J, Berndt JD, Gonzalez-Lima F. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 2001;21:4923-30. (Pubitemid 32565651)
69. de la Torre JC. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol 2012;2012:367516.
70. Sokoloff L, Siegel BW, Agranoff BW, Albers RW, Molinoff P. Circulation and energy metabolism of the brain. Boston: Little Brown; 1989.
71. Poyton RO, Castello PR, Ball KA, Woo DK, Pan N. Mitochondria and hypoxic signaling: a new view. Ann NY Acad Sci 2009;1177:48-56.
72. Bangen KJ, Restom K, Liu TT, Wierenga CE, Jak AJ, Salmon DP, et al. Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study. J Alzheimers Dis 2012;31(Suppl 3):S59-74.
73. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005;234:851-9. (Pubitemid 40250829)
74. Mak HK, Chan Q, Zhang Z, Petersen ET, Qiu D, Zhang L, et al. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal elderly adults at 3- tesla. J Alzheimers Dis 2012;31:33-44.
75. Poyton RO, Ball KA. Therapeutic photobiomodulation: nitric oxide and a novel function of mitochondrial cytochrome c oxidase. Discov Med 2011;11:154-9.